| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.3 |